Stryker finalized its acquisition of Invuity.
In September, Stryker announced plans to acquire the company for $190 million, or $7.40 per share. The acquisition is expected to have an immaterial impact on Stryker's net earnings in 2018.
Invuity develops photonics and single-use, lighted instruments to enhance visualization for a wide variety of clinical applications, including orthopedic and spine surgery.